TEAD4 and neoplasm: Our study systematically analyzed the TME in patients with LUAD and demonstrated that a high expression of TEAD4 is associated with a poor anti-tumor immune response, with evidence of a lower immune score and HLA family components and higher levels of immune checkpoint genes in the high-risk subgroups based on the high TEAD4 expression.